Springboard Corner: February 2022

Feb 9, 2022


Welcome To The Springboard Corner

We are just one month into the new year, and things are already heating up in San Diego’s innovation community!
This here marks the first of semi-regular postings designed to highlight and share recent milestones of life science and hi-tech startups which we have worked with through Connect’s Springboard program.

The big announcement last month was the news of Classy’s acquisition by GoFundMe. A leader in online fundraising through their proprietary technology platform, and founded in 2006, Classy has helped over 6,000 nonprofits raise in excess of $3 billion for social good causes.

Abreos Biosciences – A precision medicine company founded in 2013, Abreos has developed a proprietary platform for dosing and monitoring of biologic drugs. They were acquired last year by and are a wholly owned subsidiary of AegirBio where they will continue to develop drug monitoring diagnostics in several areas including oncology, immunology and neurology.

DTx Pharma – A drug discovery company which develops novel RNA-based therapeutics for personalized treatments for neuromuscular, ocular and CNS diseases, DTx was founded in 2017. By using fatty acids, they are developing new therapeutics which can be effectively delivered and taken up by the cells which other therapeutic modalities cannot effectively manage. They raised a $100.2M Series B round last year to further advance their assets towards clinical development.

Fabric8Labs – An additive manufacturing company which has developed an innovative non-thermal process to 3D metal printing, the company was founded in 2015. They raised a $19.2M Series A round last year.

Independa – This award-winning company was founded in 2009 and delivers solutions which enable older adults to receive remote engagement and care while maintaining their independence in the residence of their choice. This year they signed a partnership with LG, making them the first telehealth company to be supported on LG TVs.

Molecular Assemblies – Founded in 2013, they have developed a proprietary enzymatic DNA synthesis technology to advance discoveries in DNA-based applications. They raised $44.1M in 2021.

NanoCellect Biomedical – Founded in 2009, they closed a $35M financing round last year. They are a leading provider in developing pioneering solutions for cell analysis and sorting using microfluidic technology. Their microfluidic flow cytometry devices are instrumental in advancing biological research and discoveries.

NeuraLace Medical – Founded in 2016, NeuraLace has developed breakthrough non-opioid systems to relieve chronic nerve pain. 2021 marked the year their Axon Therapy® system received 510(K) clearance by the FDA, finally paving the way for this innovation to become commercially available in the U.S.

San Diego is on a roll and we can’t wait to see what the rest of the first quarter brings!